Biblio

Export 220 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
B. Dubois, “The Emergence of a New Conceptual Framework for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1059-1066, 2018.
X. Guo, Zhang, G., Peng, Q., Huang, L., Zhang, Z., and Zhang, Z., “Emerging Roles of Meningeal Lymphatic Vessels in Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S355-S366, 2023.
A. Imai, Matsuoka, T., and Narumoto, J., “Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.”, J Alzheimers Dis, vol. 93, no. 2, pp. 521-532, 2023.
H. Hochstetler, Trzepacz, P. T., Wang, S., Yu, P., Case, M., Henley, D. B., Degenhardt, E., Leoutsakos, J. - M., and Lyketsos, C. G., “Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., “Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
A. Wimo, “The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.”, J Alzheimers Dis, 2018.
A. Llorente-Ovejero, Manuel, I., Lombardero, L., Giralt, M. Teresa, Ledent, C., Giménez-Llort, L., and Rodríguez-Puertas, R., “Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 1, pp. 117-136, 2018.
M. Domínguez-Prieto, Velasco, A., Tabernero, A., and Medina, J. M., “Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1109-1124, 2018.
B. Ahlemeyer, Halupczok, S., Rodenberg-Frank, E., Valerius, K. - P., and Baumgart-Vogt, E., “Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1425-1450, 2018.
P. Almeida-Meza, Steptoe, A., and Cadar, D., “Is Engagement in Intellectual and Social Leisure Activities Protective Against Dementia Risk? Evidence from the English Longitudinal Study of Ageing.”, J Alzheimers Dis, vol. 80, no. 2, pp. 555-565, 2021.
A. Brugulat-Serrat, Cañas, A., Canals, L., Marne, P., Gramunt, N., Milà-Alomà, M., Suárez-Calvet, M., Arenaza-Urquijo, E. M., Grau-Rivera, O., González-de-Echávarri, J. María, Minguillon, C., Fauria, K., Kollmorgen, G., Suridjan, I., Zetterberg, H., Blennow, K., Gispert, J. Domingo, Molinuevo, J. Luis, and Sánchez-Benavides, G., “Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.”, J Alzheimers Dis, vol. 84, no. 1, pp. 119-128, 2021.
K. J. Bangen, Thomas, K. R., Sanchez, D. L., Edmonds, E. C., Weigand, A. J., Delano-Wood, L., and Bondi, M. W., “Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1711-1725, 2021.
D. Cutuli, Landolfo, E., Petrosini, L., and Gelfo, F., “Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
L. Calderón-Garcidueñas, Torres-Jardón, R., Franco-Lira, M., Kulesza, R., González-Maciel, A., Reynoso-Robles, R., Brito-Aguilar, R., García-Arreola, B., Revueltas-Ficachi, P., Barrera-Velázquez, J. Adriana, García-Alonso, G., García-Rojas, E., Mukherjee, P. S., and Delgado-Chávez, R., “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
G. T. Sutherland, Lim, J., Srikanth, V., and Bruce, D. G., “Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia.”, J Alzheimers Dis, vol. 59, no. 2, pp. 393-403, 2017.
J. Gräff, Rei, D., Guan, J. - S., Wang, W. - Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., Su, S. C., Samiei, A., Joseph, N., Haggarty, S. J., Delalle, I., and Tsai, L. - H., “An epigenetic blockade of cognitive functions in the neurodegenerating brain.”, Nature, vol. 483, no. 7388, pp. 222-6, 2012.
P. Chatterjee, Roy, D., and Rathi, N., “Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.”, J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
D. Arnaldi, Donniaquio, A., Mattioli, P., Massa, F., Grazzini, M., Meli, R., Filippi, L., Grisanti, S., Famá, F., Terzaghi, M., Girtler, N., Brugnolo, A., Doglione, E., Pardini, M., Villani, F., and Nobili, F., “Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”, J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
B. Cretin, Sellal, F., Philippi, N., Bousiges, O., Di Bitonto, L., Martin-Hunyadi, C., and Blanc, F., “Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?”, J Alzheimers Dis, vol. 52, no. 3, pp. 1125-33, 2016.
G. Hautecloque-Raysz, Sellal, F., Bousiges, O., Phillipi, N., Blanc, F., and Cretin, B., “Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1057-1074, 2023.
J. E. Baker, Lim, Y. Ying, Jaeger, J., Ames, D., Lautenschlager, N. T., Robertson, J., Pietrzak, R. H., Snyder, P. J., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P., “Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
M. Fernández-Matarrubia, Matías-Guiu, J. A., Cabrera-Martín, M. Nieves, Moreno-Ramos, T., Valles-Salgado, M., Carreras, J. Luis, and Matías-Guiu, J., “Episodic Memory Dysfunction in Behavioral Variant Frontotemporal Dementia: A Clinical And FDG-PET Study.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1251-1264, 2017.
I. Baghallab, Reyes-Ruiz, J. Mauricio, Abulnaja, K., Huwait, E., and Glabe, C., “Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1235-1244, 2018.
R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Stott, S. R. W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R. P., Holland, A., and Zaman, S. H., “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
A. Suzuki, Shinozaki, J., Yazawa, S., Ueki, Y., Matsukawa, N., Shimohama, S., and Nagamine, T., “Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1653-1665, 2018.

Pages